Biological Evaluation (Lecture – 9) Reference standards Joseph O. Oweta B. Pharm (MUST)

Slides:



Advertisements
Similar presentations
Fundamentals of Pharmacology for Veterinary Technicians
Advertisements

Dr. Birgit Schmauser, BfArM, Bonn
Biopharmaceutical Quality
Analytical Method Development and Validation
1 The management and technical evaluation requirements of chemical drug substances State Food and Drug Administration Center for Drug Evaluation March.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
World Health Organization
World Health Organization
SOURCES OF PHARMACEUTICAL INFORMATION. 1-Pharmacopeias Pharmacopoeia is a book containing an official list of the drugs used in medicine together with.
Quality Assurance.
Reference standards Bujji Kanchi.
Quality control of raw materials In-process control
VALIDATION OF RAW MATERIALS
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
Lecture – DR. SHAHNAZ USMAN Associate Professor Dept. of Pharmaceutics RAKMHSU PHARMACOPOEIAS AND OTHER OFFICIAL COMPENDIA 1.
Quality Assurance.
Selection Sourcing Structure Standardization Safety Substantiation
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on Reference standards Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM,
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
Introduction to Analytical Chemistry
Stefan Franzén Introduction to clinical trials.
Introduction to Analytical Chemistry Dr M. Abd-Elhakeem Faculty of Biotechnology General Chemistry Lecture 7.
Exploratory IND Studies
Copyright (c) The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 9-1 Chapter 9 Principles of Pharmacology.
Quality Control Lecture 5
Laboratory tests Interpreting results. Why tests are needed Detection, Diagnosis and Treatment of diseases in patients Presence, extent, or absence of.
BNF for children and formulations Ian Costello British National Formulary.
Bioavailability Dr Mohammad Issa.
INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT. INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT Indian Pharmacopoeia Commission (IPC) Vision The IPC is committed.
CHEMICAL ANALYSIS BY Dr.JAGADEESH. CHEMICAL ANALYSIS RESOLVING A SAMPLE IN TO ITS ULTIMATE COMPONENTS ( COMPOUNDS OR ELEMENTS)
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
HELM AG Module 3 Christa Clasen Ankara, 6./7. April 2006.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on impurities Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM, Council.
Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview
1 Is it potent? Can these results tell me? Statistics for assays Ann Yellowlees PhD Quantics Consulting Limited.
ORGANIZATION OF THE MEDICINE QUALITY CONTROL SYSTEM IN PHARMACY.
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
Bioassays.
Malaysia, EVALUTION OF DOSSIERS IN WHO- PREQUALIFICATION PROJECT MULTISOURCE TB-DRUGS Evaluation of bioavailability/bioequivalence data Based,
Yewande Dayo Student Pharmacist
Substance Structure, production process and indented use Is there adequate published safety data and exposure data for this substance to meet current GRAS.
Quality Control Internal QC External QC. -Monitors a test's method precision and analytical bias. -Preparation of quality control samples and their interpretation.
LECTURE 13 QUALITY ASSURANCE METHOD VALIDATION
Primary Standards Is a highly purified compound that serves as a reference material in all volumetric and titrimetric methods. It must be: –1) Highly pure,
Biological Evaluation Lecture - 3 Principles and Importance of BA’s Joseph O. Oweta B. Pharm (MUST)
QbD Technologies: Workshop for Risks Management Incorporating Risk Management for Technology Transfer.
1.  It is defined in the regulations as “all products made of any materials of any nature to be used for the containment, protection, handling, delivery.
Biological Evaluation Lecture - 4 Principles and Importance of BA’s Joseph O. Oweta B. Pharm (MUST)
OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.
Chapter 1: The Nature of Analytical Chemistry
Adulteration and Evaluation of Crude drugs
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Medicinal Chemistry Lecture – I Introduction and Course Overview Joseph O. Oweta B. Pharm (MUST)
QbD Technologies: Workshop for Risks Management Incorporating Risk Management for Technology Transfer.
BSB Biomanufacturing CHAPTER 11 GMP – Pharmaceutical Water
QUANTITATIVE ANALYTICAL CHEMISTRY PRACTICES
Quality Control of Herbal Drug
Guidance for review of studies involving HCT/Ps and IND Basics
Physico-chemical Control of Dosage Forms
Solid dosage forms Tablets
WHO Technical Report Series, No. 953, 2009
Forensic Drug Analysis
Dr. Pandit Khakre Asst. Prof Mrs. K.S.K. College, Beed.
ANALYTICAL METHOD VALIDATION
Introduction To Medical Technology
▪Internal quality control:
Quality guidelines on impurities
Quality guidelines on impurities
Presentation transcript:

Biological Evaluation (Lecture – 9) Reference standards Joseph O. Oweta B. Pharm (MUST)

Objectives Overview & basic principles Sources & Preparation of reference standards Assay of Digitaloid drugs

Overview and Basic Principles “Reference standards….are highly characterised specimens reflective of specified drugs and foods (drug substances, biologics, excipients, dietary supplements, food ingredients, impurities, degradation products, reagents and performance verification standards.” USP

Overview and Basic Principles “A REFERENCE STANDARD is a highly purified compound, substance or product (or a standardized procedure) that is well characterized.” Hence may serve as guides to ensure the quality of subsequent compounds, procedures or products are in conformity with set (lay down) specifications of the standard. Reference Standards are divided into four main categories: – Primary, – Secondary, – Reagent grades – and Pharmacopeia

Primary Standard Is an analytical reagent of generally high purity and documentation confirming the results four or five of the following tests: HPLC, NMR, GC, TLC, LCMS, Karl Fischer and a Residual Solvents analysis. The parameters of the method of testing will also be provided along with these results of testing.

Secondary Standard Is generally of a lesser purity than a Primary standard. The defining difference between the two is that secondary standards have only one or two test results, usually HPLC and one other. These standards are also provided with a method of testing.

Reagent / Standard Grade Are separated from primary and secondary reference standards due to a lack of characterization and documentation of the batch compound. There is a Certificate of Analysis provided with the compound however no guaranteed method of analysis will be provided.

Pharmacopeias Reference Standard Pharmacopeia is predominantly a collection of specifications to primarily serve as a guide to manufacturers, pharmacists and regulatory agencies in carrying out their respective drug related activities with respect to the quality of drugs and pharmaceutical products.

Pharmacopeias Reference Standard Specifications 1.Purity 2.Potency 3.Test methodology 4.Standards for independent evaluation of drug quality 5.Identification properties and physical characteristics 6.Ultimate composition of substances as well as medicinal formulae 7.Presence or/and absence of traces of foreign substances

Pharmacopeias Reference Standard Importance 1.Promotes improvement of pharmaceutical products. 2.Ensures the maintaining of high quality products within and across countries. 3.Serves as a quick reference for drugs, medicinal drugs product, raw material and (small scale) manufacturing procedure. 4.Provides readily available reference to verify drugs and pharmaceutical products in the international market. 5.Easy reference for drug storage, labelling, use, dose regimen, strength etc.

Pharmacopeias Reference Standard Specifications British Pharmacopeia (BP) United States Pharmacopeias (USP) British Pharmaceutical Codex (BPC) European Pharmacopeia International Pharmacopeia (IP) African Pharmacopeia (AP) Pharmacopeia of India

Overview and Basic Principles (Recap – of principles of BA) The reference standard and test sample should have the same pharmacological effects and should have the same mode of action….Parallelism The test solution and reference standard should be compared for their established pharmacological effect using a specified pharmacological technique

Reference Standards Used to minimise error resulting from animal variation in certain bioassay procedures. Principle consists of testing unknown and standard on: – Two gps of similar animals – Same animal and organ (Some cases)

Reference Standards Amount of unknown rqd. to produce and effect in ref. to the std. is inv. Proportional to the potency. Potency of unknown can be expressed as a percentage of that of the standard. Precise methods of determining potency may be based upon observation on relative and not equal effects.

Assay of Digitaloid Drugs Group of drugs including digitalis (Dried leaves of D. Purpurea). Contains cardioactive glycosides – Digitoxin – Gitoxin Digitonin - saponin like glycoside largely devoid of cardiac effects of digitalis Complex mixture – Digitoflavin – Digitophyllin – Lipids – Carbohydrates

Assay of Digitaloid Drugs Cardioactive structures are similar: – Chemical structure – Pharmacodynamics (+ inotropic effect) Differ markedly in: – milligram potency. – Onset of activity – Duration of action Crude drugs also vary in: – Total glycoside content – Relative concentration of each active principle

Assay of Digitaloid Drugs Chemical Assays?? May determine total glycosides or total aglycones. Cannot measure the total p’dynamic activity of: – Crude drug – Galenical preparations Such drugs must be subjected to bioassays.

Bioassay of Digitalis Based on amount of a test material required to cause death due to cardiac arrest in the anaesthetised pigeon…. …relative to the amount of standard required to produce the same effect.

Bioassay of Digitalis Challenges/ limitations Fractional intermittent intravenous administration is used to model oral administration. – Variations in clinical effectives of different constituents not accounted for. Toxic end point considered instead of a therapeutic end point However, its argued that the toxic effects on the heart constitute an extension of the beneficial. No alternative presents a comparative advantage over the official method.

Bioassay of Digitalis Seperation and x-terisation has led to the availability of pure relatively pure cardiotonic glycosides. – Digoxin – Digitoxin – Acetyldigitoxin – Ouabain The above preparations are assayed quantitatively using spectroscopic methods.

Bioassay of Digitalis Chemical assays enable precise determination. However patient response varies for digitaloid drugs. A clinical assay must be performed with each patient…regardless of: – Chemical assay (single drug formulations) – Bioassay (homeopathy)

Digitalis Assay Digitalis Powdered digitalis Digitalis capsules Digitalis

Next week….Insulin & Glucagon assays